PharmEasy parent appoints 5 independent directors

Published On 2021-09-13 10:34 GMT   |   Update On 2021-09-13 10:34 GMT

New Delhi: API Holdings, the parent company of PharmEasy, on Monday said it has appointed five independent directors to its Board.The fresh appointments bring a great amount of cognitive diversity to the Board, with luminaries from the world of public service, technology, pharma, medical fraternity, and the consumer sector, API Holdings Ltd said in a statement.The five new independent...

Login or Register to read the full article

New Delhi: API Holdings, the parent company of PharmEasy, on Monday said it has appointed five independent directors to its Board.

The fresh appointments bring a great amount of cognitive diversity to the Board, with luminaries from the world of public service, technology, pharma, medical fraternity, and the consumer sector, API Holdings Ltd said in a statement.

The five new independent directors are -- Vineeta Rai, former revenue secretary; retired CFO of Titan Company Ltd Subramanian Somasundaram; Livspace Founder and COO Ramakant Sharma, Federation of Obstetric and Gynaecological Societies of India Secretary General Jaydeep Tank and private equity veteran Deepak Vaidya, it added.

Read also: Empowering vaccine takers: PharmEasy launches Go Corona Go Initiative

"This is yet another step in our journey of being the best in the class of Corporate Governance, and lead the way for times to come. The diversity will help us provide integrated, digital healthcare solutions across the length and breadth of India benefiting all stakeholders," API Holdings co-founder and CEO Siddharth Shah said.

Read also: PharmEasy to acquire 66.1 percent stake in Thyrocare for Rs 4546 crore



Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News